Loading...
The Financial Express

Search results for: Health

Countries rush to purchase experimental antiviral COVID-19 pills

Countries rush to purchase experimental antiviral COVID-19 pills

-- 2021-12-31 10:53:58

The US Food and Drug Administration (FDA) last week authorised Merck's antiviral COVID-19 pill for high-risk adult patients, a day after giving a broader go-ahead to a similar but more effective treat...

Omicron cannot escape T cells; boosters protect households from Omicron

Omicron cannot escape T cells; boosters protect households from Omicron

-- 2021-12-30 18:36:28

The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review, reports Re...

Asia keeps omicron at bay, but a surge may be inevitable

Asia keeps omicron at bay, but a surge may be inevitable

-- 2021-12-29 15:27:18

Much of Asia has largely managed to keep omicron at bay even as the variant rages in other parts of the world, but the region that is home to most of the globe’s population is bracing for what m...

South Africa study suggests Omicron variant could displace Delta

South Africa study suggests Omicron variant could displace Delta

-- 2021-12-29 12:40:03

Research by South African scientists suggests that Omicron could displace the Delta variant of the coronavirus because infection with the new variant boosts immunity to the older one, reports Reuters....

South Africa study suggests Omicron could displace Delta

South Africa study suggests Omicron could displace Delta

-- 2021-12-28 19:10:56

Research by South African scientists suggests that Omicron could displace the Delta variant of the coronavirus because infection with the new variant boosts immunity to the older one. The study only...

The importance of adverse event reporting

The importance of adverse event reporting

Imtiaz Ahmed 2021-12-28 17:39:04

We are all familiar with side effects of drugs. Worldwide this term has been replaced by “Adverse Event” (AE), a broader umbrella that included a lot of things apart from side effects. U...

India allows emergency use of Merck's Covid-19 pill

India allows emergency use of Merck's Covid-19 pill

-- 2021-12-28 13:34:26

India gave emergency use authorisation (EUA) for Merck's Covid-19 pill molnupiravir, and Serum Institute of India's Covovax and Biological E's Corbevax coronavirus vaccines, the country's health minis...

France further tightens COVID measures

France further tightens COVID measures

-- 2021-12-28 10:26:36

French Prime Minister Jean Castex said that in response to a rapid spread of the omicron variant of COVID-19, the government is narrowing the delay for a third booster shot to three months from four,...

US FDA authorises Merck's at-home antiviral COVID-19 pill

US FDA authorises Merck's at-home antiviral COVID-19 pill

-- 2021-12-23 21:49:37

The US Food and Drug Administration on Thursday authorised Merck & Co's antiviral pill for COVID-19 for certain high-risk adult patients, a day after giving the go-ahead to similar treatment from...

Incoming COVID-19 pills are no substitute for vaccines, disease experts say

Incoming COVID-19 pills are no substitute for vaccines, disease experts say

-- 2021-12-23 19:41:53

Oral antiviral pills from Merck & Co and Pfizer Inc have been shown to significantly blunt the worst outcomes of COVID-19 if taken early enough, but doctors warn vaccine hesitant people not to con...

AstraZeneca vaccine booster works against omicron, Oxford study finds

AstraZeneca vaccine booster works against omicron, Oxford study finds

-- 2021-12-23 16:01:10

A three-dose course of AstraZeneca's COVID-19 vaccine is effective against the rapidly-spreading omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an Oxford Un...

India’s Serum waives AstraZeneca shot indemnity for refugee programme

India’s Serum waives AstraZeneca shot indemnity for refugee programme

-- 2021-12-23 10:12:31

The Serum Institute of India (SII) has waived its protection from legal liabilities for any AstraZeneca-Oxford COVID-19 shots it supplies to a global programme for refugees, a spokesperson for the GAV...

AstraZeneca, Oxford aim to produce Omicron-targeted vaccine

AstraZeneca, Oxford aim to produce Omicron-targeted vaccine

-- 2021-12-22 17:35:50

AstraZeneca Plc said on Tuesday it is working with Oxford University to produce a vaccine for the Omicron coronavirus variant, joining other vaccine-makers who are looking to develop the variant-speci...

Registration for booster dose to begin at the end of December,  minister says

Registration for booster dose to begin at the end of December, minister says

-- 2021-12-21 18:39:36

Health Minister Zahid Maleque on Tuesday said the registration through ‘Surokkha’ App for administering Covid-19 booster dose will start at the end of December after updating the app. &ld...

Omicron spreading faster than Delta, infecting vaccinated people too: WHO

Omicron spreading faster than Delta, infecting vaccinated people too: WHO

-- 2021-12-21 17:13:54

The omicron variant of the coronavirus is spreading faster than the Delta variant and is causing infections in people already vaccinated or who have recovered from the COVID-19 disease, the head of th...

Leaving scissors in body after surgery not a new mistake, probe body says

Leaving scissors in body after surgery not a new mistake, probe body says

-- 2021-12-21 16:45:26

A doctors' group probing an incident at the Bangabandhu Sheikh Mujib Medical College Hospital in Faridpur, during which a pair of six-inch surgical scissors were left in a girl’s abdomen after s...

Moderna could be ready to develop omicron booster in weeks: CEO

Moderna could be ready to develop omicron booster in weeks: CEO

-- 2021-12-21 16:38:39

COVID-19 vaccine maker Moderna does not expect any problems in developing a booster shot to protect against the omicron variant of the coronavirus and could begin work in a few weeks, Chief Executive...

Why Bangladeshi patients seek treatment abroad

Why Bangladeshi patients seek treatment abroad

-- 2021-12-21 11:09:49

Even though there are top-notch doctors in Bangladesh, many people fly abroad for treatment as they cannot rely on the local medical systems, according to both healthcare experts and patients, UNB rep...

Moderna says booster dose appears protective against Omicron

Moderna says booster dose appears protective against Omicron

-- 2021-12-20 17:26:52

Moderna Inc said on Monday that a booster dose of its COVID-19 vaccine appeared to be protective against the fast-spreading Omicron variant in laboratory testing and that the current version of the va...

Trials of stem cell therapy offer hope to childless women in Bangladesh

Trials of stem cell therapy offer hope to childless women in Bangladesh

-- 2021-12-19 17:27:20

A team of doctors from Bangabandhu Sheikh Mujib Medical University has launched clinical trials of stem cell therapy for ovarian regeneration and oocyte generation, offering hope to women with inferti...

Booster dose for health workers from Sunday

Booster dose for health workers from Sunday

-- 2021-12-18 16:57:21

Covid-19 booster doses will be administered to health workers on a trial basis from Sunday, said Dr Abu Hossain Md Mainul Ahsan, the Civil Surgeon of Dhaka district, reports bdnews24.com.  &ldqu...

Omicron cases doubling in 1.5 to 3 days in areas with local spread : WHO

Omicron cases doubling in 1.5 to 3 days in areas with local spread : WHO

-- 2021-12-18 16:39:58

The Omicron coronavirus variant has been reported in 89 countries and the number of cases is doubling in 1.5 to 3 days in areas with community transmission, the World Health Organization (WHO) said on...

New study says Omicron five times more likely to reinfect than Delta

New study says Omicron five times more likely to reinfect than Delta

-- 2021-12-18 10:54:29

The risk of reinfection with the Omicron coronavirus variant is more than five times higher and it has shown no sign of being milder than Delta, a study showed, as cases soar across Europe and threate...

Omicron rewrites the COVID plan for 2022

Omicron rewrites the COVID plan for 2022

-- 2021-12-17 18:16:57

As the omicron variant gains momentum in Europe and the United States, scientists are rewriting their expectations for the COVID-19 pandemic next year, reports Reuters.  Just weeks ago, disease...

Study suggests vaccines may be ineffective against Omicron without booster

Study suggests vaccines may be ineffective against Omicron without booster

-- 2021-12-17 10:07:25

All three US-authorised Covid-19 vaccines appear to be significantly less protective against the newly-detected Omicron variant of the coronavirus in laboratory testing, but a booster dose likely rest...

WHO issues recommendations for mixing and matching Covid-19 vaccines

WHO issues recommendations for mixing and matching Covid-19 vaccines

-- 2021-12-17 09:53:38

The World Health Organization issued interim recommendations on Thursday for mixing and matching Covid-19 vaccines from different manufacturers for both the second dose and booster shots. Depending o...

AstraZeneca antibody cocktail works against omicron, US study says

AstraZeneca antibody cocktail works against omicron, US study says

-- 2021-12-16 20:58:17

AstraZeneca on Thursday said a lab-study of its COVID-19 antibody cocktail, Evusheld, found that the treatment retained neutralising activity against the omicron coronavirus variant, showing promise f...

EU regulator okays COVID-19 treatments from GSK-Vir and Sobi

EU regulator okays COVID-19 treatments from GSK-Vir and Sobi

-- 2021-12-16 20:48:22

The European Union's drug regulator on Thursday approved a COVID-19 treatment from British-US duo GSK and Vir Biotechnology and another from Swedish drugmaker Sobi, as the bloc builds its defences aga...

Omicron thrives in airways, not lungs, suggest new data

Omicron thrives in airways, not lungs, suggest new data

FE ONLINE DESK 2021-12-16 11:40:43

Major differences in how efficiently Omicron and other variants of the coronavirus multiply may help predict Omicron's effects, researchers said on Wednesday. Compared to the earlier Delta variant, O...

Pfizer set to oust AstraZeneca as top supplier of COVID-19 shots to poor nations

Pfizer set to oust AstraZeneca as top supplier of COVID-19 shots to poor nations

FE ONLINE DESK 2021-12-15 15:44:27

Pfizer and BioNtech are set to displace AstraZeneca as the main suppliers of COVID-19 vaccines to the global COVAX programme at the start of 2022, a shift that shows the increasing importance of their...